Given that increases in CSF p-tau are unique to AD, and are not observed in other tauopathies, it is hypothesised that p-tau may be a measure of Aβ-induced tau phosphorylation (Maia et al., 2013; Kanmert et al., 2015; Sato et al., 2018). Here, MAPT is linked to Alzheimer disease.